title: Efficacies of zinc-finger-active drugs against Giardia lamblia.
abstract: Twenty-nine of 34 (85%) Zn-finger-active compounds at 300 microM or less inhibited the growth of Giardia lamblia. The most active compound, disulfiram (Antabuse), was cidal at 1.23 +/- 0.32 microM. In the adult mouse model, significant in vivo activity was demonstrated by increased cure rates and decreased parasite burdens.
authors.affiliation: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. tnash@atals.niaid.nih.gov
authors.forename: T
authors.initials: T
authors.lastname: Nash
authors.forename: W G
authors.initials: WG
authors.lastname: Rice
mesh_terms: D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004221:Disulfiram / Q000494:pharmacology* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D016829:Giardia lamblia / Q000187:drug effects*; D005873:Giardiasis / Q000188:drug therapy; D051379:Mice; D016335:Zinc Fingers / Q000187:drug effects*
chemical_list: D000981:Antiprotozoal Agents; D004221:Disulfiram